The diagnosis and management of acute bacterial meningitis in resource-poor settings

The Lancet Neurology

Volumn 7, Issue 7, 2008, Pages 637-648

  Scarborough, Matthew ^a   Thwaites, Guy E ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; DEXAMETHASONE; GLYCEROL; PENICILLIN G; PLACEBO; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADD ON THERAPY; ANTIBIOTIC RESISTANCE; BACTERIAL MENINGITIS; BLOOD TESTIS BARRIER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG COST; FLUID RESUSCITATION; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION SENSITIVITY; LISTERIOSIS; LUMBAR PUNCTURE; MICROBIOLOGY; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; REHYDRATION; REVIEW; STREPTOCOCCUS PNEUMONIA; THERAPY DELAY; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; VACCINATION;

ANIMALS; DEVELOPING COUNTRIES; HEALTH RESOURCES; HUMANS; MENINGITIS, BACTERIAL;

EID: 49849086286     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70139-X     Document Type: Review

References (124)

1. Baraff L., Lee S., and Schriger D. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 12 (1993) 389-394
2. Swartz M. Bacterial meningitis-a view of the past 90 years. N Engl J Med 351 (2004) 1826-1828
3. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 11 (1992) 694-698
4. Berkley J., Versteeg A., Mwangi I., Lowe B., and Newton C. Indicators of acute bacterial meningitis in children at a rural Kenyan district hospital. Pediatrics 114 (2004) e713-e719
5. Lehmann D., Yeka W., Rongap T., et al. Aetiology and clinical signs of bacterial meningitis in children admitted to Goroka Base Hospital, Papua New Guinea, 1989-1992. Ann Trop Paediatr 19 (1999) 21-32
6. Weber M., Herman J., Jaffar S., et al. Clinical predictors of bacterial meningitis in infants and young children in The Gambia. Trop Med Int Health 7 (2002) 722-731
7. Durand M., Calderwood S., Weber D., et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328 (1993) 21-28
8. Thomas K., Hasbun R., Jekel J., and Quagliarello V. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis 35 (2002) 46-52
9. Aronin S., Peduzzi P., and Quagliarello V. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129 (1998) 862-869
10. van de Beek D., de Gans J., Spanjaard L., Weisfelt M., Reitsma J., and Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351 (2004) 1849-1859
11. Attia J., Hatala R., Cook D., and Wong J. The rational clinical examination. Does this adult patient have acute meningitis?. JAMA 282 (1999) 175-181
12. Thwaites C., Yen L., Glover C., et al. Predicting the clinical outcome of tetanus: the tetanus severity score. Trop Med Int Health 11 (2006) 279-287
13. Puxty J., Fox R., and Horan M. The frequency of physical signs usually attributed to meningeal irritation in elderly patients. J Am Geriatr Soc 31 (1983) 590-592
14. Berkley J., Mwangi I., Ngetsa C., et al. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet 357 (2001) 1753-1757
15. Arditi M., Mason Jr. E., Bradley J., et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102 (1998) 1087-1097
16. Green S., Rothrock S., Clem K., Zurcher R., and Mellick L. Can seizures be the sole manifestation of meningitis in febrile children?. Pediatrics 92 (1993) 527-534
17. Weisfelt M., van de Beek D., Spanjaard L., and de Gans J. Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study. BMC Infect Dis 6 (2006) 64
18. Mai N., Hoa N., Nga T., et al. Streptococcus suis meningitis in adults in Vietnam. Clin Infect Dis 46 (2008) 659-667
19. Mwaba P., Mwansa J., Chintu C., et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 77 (2001) 769-773
20. Thwaites G., and Tran T. Tuberculous meningitis: many questions, too few answers. Lancet Neurol 4 (2005) 160-170
21. Hakim J., Gangaidzo I., Heyderman R., et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 14 (2000) 1401-1407
22. Heyderman R., Gangaidzo I., Hakim J., et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 26 (1998) 284-289
23. Mai N., Chau T., Thwaites G., et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 357 (2007) 2431-2440
24. Lee B., and Davies H. Aseptic meningitis. Curr Opin Infect Dis 20 (2007) 272-277
25. Bergemann A., and Karstaedt A. The spectrum of meningitis in a population with high prevalence of HIV disease. QJM 89 (1996) 499-504
26. Bekondi C., Bernede C., Passone N., et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis 10 (2006) 387-395
27. McIntyre J., and Keen G. Laboratory surveillance of viral meningitis by examination of cerebrospinal fluid in Cape Town, 1981-9. Epidemiol Infect 111 (1993) 357-371
28. Reyburn H., Mbatia R., Drakeley C., et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 329 (2004) 1212
29. Scarborough M., Gordon S., Whitty C., et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 357 (2007) 2441-2450
30. Berkley J., Mwangi I., Mellington F., Mwarumba S., and Marsh K. Cerebral malaria versus bacterial meningitis in children with impaired consciousness. QJM 92 (1999) 151-157
31. Njama-Meya D., Clark T., Nzarubara B., Staedke S., Kamya M., and Dorsey G. Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children. Malar J 6 (2007) 7
32. Chandler C., Jones C., Boniface G., Juma K., Reyburn H., and Whitty C. Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar J 7 (2008) 53
33. Berkley J., Maitland K., Mwangi I., et al. Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. BMJ 330 (2005) 995
34. Wright P., Avery W., Ardill W., and McLarty J. Initial clinical assessment of the comatose patient: cerebral malaria vs. meningitis. Pediatr Infect Dis J 12 (1993) 37-41
35. Trachtenberg J., Kambugu A., McKellar M., et al. The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. Int J Infect Dis 11 (2007) 524-530
36. English M., Esamai F., Wasunna A., et al. Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya. Lancet 363 (2004) 1948-1953
37. Joffe A. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med 22 (2007) 194-207
38. Tunkel A., Hartman B., Kaplan S., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 (2004) 1267-1284
39. Gopal A., Whitehouse J., Simel D., and Corey G. Cranial computed tomography before lumbar puncture: a prospective clinical evaluation. Arch Intern Med 159 (1999) 2681-2685
40. Hasbun R., Abrahams J., Jekel J., and Quagliarello V. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 345 (2001) 1727-1733
41. Oliver W., Shope T., and Kuhns L. Fatal lumbar puncture: fact versus fiction-an approach to a clinical dilemma. Pediatrics 112 (2003) e174-e176
42. Thwaites G., Chau T., Stepniewska K., et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360 (2002) 1287-1292
43. Schut E., de Gans J., and van de Beek D. Community-acquired bacterial meningitis in adults. Pract Neurol 8 (2008) 8-23
44. Coll M., Uriz M., Pineda V., et al. Meningococcal meningitis with 'normal' cerebrospinal fluid. J Infect 29 (1994) 289-294
45. Huynh W., Lahoria R., Beran R., and Cordato D. Meningococcal meningitis and a negative cerebrospinal fluid: case report and its medicolegal implications. Emerg Med Australas 19 (2007) 553-555
46. Uchihara T., Ichikawa K., Yoshida S., and Tsukagoshi H. Positive culture from normal CSF of Streptococcus pneumoniae meningitis. Eur Neurol 36 (1996) 234
47. Negrini B., Kelleher K., and Wald E. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 105 (2000) 316-319
48. Logan S., and MacMahon E. Viral meningitis. BMJ 336 (2008) 36-40
49. Spanos A., Harrell Jr. F., and Durack D. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA 262 (1989) 2700-2707
50. Maher D., and Mwandumba H. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. J Infect 28 (1994) 59-64
51. Moosa A., Quortum H., and Ibrahim M. Rapid diagnosis of bacterial meningitis with reagent strips. Lancet 345 (1995) 1290-1291
52. Romanelli R., Thome E., Duarte F., Gomes R., Camargos P., and Freire H. [Diagnosis of meningitis with reagent strips]. J Pediatr (Rio J) 77 (2001) 203-208
53. Parmar R., Warke S., Sira P., and Kamat J. Rapid diagnosis of meningitis using reagent strips. Indian J Med Sci 58 (2004) 62-66
54. Heckmann J., Engelhardt A., Druschky A., Muck-Weymann M., and Neundorfer B. [Urine test strips for cerebrospinal fluid diagnosis of bacterial meningitis]. Med Klin (Munich) 91 (1996) 766-768
55. Molyneux E., Walsh A., Phiri A., Soko D., Tembo M., and Howarth I. Does the use of urinary reagent strip tests improve the bedside diagnosis of meningitis?. Trans R Soc Trop Med Hyg 93 (1999) 409-410
56. Maclennan C., Banda E., Molyneux E., and Green D. Rapid diagnosis of bacterial meningitis using nitrite patch testing. Trop Doct 34 (2004) 231-232
57. Fitch M., and van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis 7 (2007) 191-200
58. Thwaites G., Chau T., and Farrar J. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 42 (2004) 378-379
59. Sato Y., Osabe S., Kuno H., Kaji M., and Oizumi K. Rapid diagnosis of cryptococcal meningitis by microscopic examination of centrifuged cerebrospinal fluid sediment. J Neurol Sci 164 (1999) 72-75
60. Kisenge P., Hawkins A., Maro V., et al. Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infect Dis 7 (2007) 39
61. Kanegaye J., Soliemanzadeh P., and Bradley J. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 108 (2001) 1169-1174
62. Talan D., Hoffman J., Yoshikawa T., and Overturf G. Role of empiric parenteral antibiotics prior to lumbar puncture in suspected bacterial meningitis: state of the art. Rev Infect Dis 10 (1988) 365-376
63. Geiseler P., Nelson K., Levin S., Reddi K., and Moses V. Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976. Rev Infect Dis 2 (1980) 725-745
64. Samra Z., Shmuely H., Nahum E., Paghis D., and Ben-Ari J. Use of the NOW Streptococcus pneumoniae urinary antigen test in cerebrospinal fluid for rapid diagnosis of pneumococcal meningitis. Diagn Microbiol Infect Dis 45 (2003) 237-240
65. Saha S., Darmstadt G., Yamanaka N., et al. Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J 24 (2005) 1093-1098
66. Cuevas L., Hart C., and Mughogho G. Latex particle agglutination tests as an adjunct to the diagnosis of bacterial meningitis: a study from Malawi. Ann Trop Med Parasitol 83 (1989) 375-379
67. Shivaprakash M., Rajagopal V., and Nagarathna S. Latex agglutination test in the diagnosis of pyogenic meningitis. J Commun Dis 36 (2004) 127-131
68. Singhal A., Lalitha M., John T., et al. Modified latex agglutination test for rapid detection of Streptococcus pneumoniae and Haemophilus influenzae in cerebrospinal fluid and direct serotyping of Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 15 (1996) 472-477
69. Maxson S., Lewno M., and Schutze G. Clinical usefulness of cerebrospinal fluid bacterial antigen studies. J Pediatr 125 (1994) 235-238
70. Tarafdar K., Rao S., Recco R., and Zaman M. Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis. Clin Infect Dis 33 (2001) 406-408
71. Nigrovic L., Kuppermann N., McAdam A., and Malley R. Cerebrospinal latex agglutination fails to contribute to the microbiologic diagnosis of pretreated children with meningitis. Pediatr Infect Dis J 23 (2004) 786-788
72. Tanner D., Weinstein M., Fedorciw B., Joho K., Thorpe J., and Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 32 (1994) 1680-1684
73. Freedman S., Marrocco A., Pirie J., and Dick P. Predictors of bacterial meningitis in the era after Haemophilus influenzae. Arch Pediatr Adolesc Med 155 (2001) 1301-1306
74. Dubos F., Lamotte B., Bibi-Triki F., et al. Clinical decision rules to distinguish between bacterial and aseptic meningitis. Arch Dis Child 91 (2006) 647-650
75. Nigrovic L., Kuppermann N., and Malley R. Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-Haemophilus influenzae era. Pediatrics 110 (2002) 712-719
76. Nigrovic L., Kuppermann N., Macias C., et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA 297 (2007) 52-60
77. Chavanet P., Schaller C., Levy C., et al. Performance of a predictive rule to distinguish bacterial and viral meningitis. J Infec 54 (2007) 328-336
78. Hoen B., Viel J., Paquot C., Gerard A., and Canton P. Multivariate approach to differential diagnosis of acute meningitis. Eur J Clin Microbiol Infect Dis 14 (1995) 267-274
79. Lewis R., Dorlencourt F., and Pinel J. Long-acting oily chloramphenicol for meningococcal meningitis. Lancet 352 (1998) 823
80. Nathan N., Borel T., Djibo A., et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 366 (2005) 308-313
81. World Health Organisation. Standardized treatment of bacterial meningitis in Africa in epidemic and non-epidemic situations (2007), World Health Organisation, Geneva
82. Prasad K., Kumar A., Gupta P., and Singhal T. Third-generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev (2007) CD001832.
83. Molyneux E., Walsh A., Forsyth H., et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 360 (2002) 211-218
84. Duke T., Michael A., Mokela D., Wal T., and Reeder J. Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?. Arch Dis Childhood 88 (2003) 536-539
85. Mwangi I., Berkley J., Lowe B., Peshu N., Marsh K., and Newton C. Acute bacterial meningitis in children admitted to a rural Kenyan hospital: increasing antibiotic resistance and outcome. Ped Infec Dis J 21 (2002) 1042-1048
86. Bercion R., Bobossi-Serengbe G., Gody J., Beyam E., Manirakiza A., and Le Faou A. Acute bacterial meningitis at the 'Complexe Pediatrique' of Bangui, Central African Republic. J Trop Peds 54 (2008) 125-128
87. van de Beek D., de Gans J., Tunkel A., and Wijdicks E. Community-acquired bacterial meningitis in adults. New Engl J Med 354 (2006) 44-53
88. Klugman K., Friedland I., and Bradley J. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. AAC 39 (1995) 1988-1992
89. Nau R., Wellmer A., Soto A., et al. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis 179 (1999) 1557-1560
90. Scarborough M., Gordon S., Whitty C., et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. New Engl J Med 357 (2007) 2441-2450
91. Tunkel A., Hartman B., Kaplan S., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39 (2004) 1267-1284
92. Roine I., Ledermann W., Foncea L., Banfi A., Cohen J., and Peltola H. Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery. Ped Infect Dis J 19 (2000) 219-222
93. Singhi P., Kaushal M., Singhi S., and Ray P. Seven days vs. 10 days ceftriaxone therapy in bacterial meningitis. J Trop Peds 48 (2002) 273-279
94. UNAIDS. AIDS epidemic update (2007), United Nations and WHO, Geneva
95. Madhi S., Madhi A., Petersen K., Khoosal M., and Klugman K. Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial meningitis in South African children. Int J Infect Dis 5 (2001) 119-125
96. Madhi S., Petersen K., Madhi A., Wasas A., and Klugman K. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Ped Infect Dis J 19 (2000) 1141-1147
97. Crewe-Brown H., Karstaedt A., Saunders G., et al. Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis 25 (1997) 1165-1172
98. Molyneux E., Walsh A., Malenga G., Rogerson S., and Molyneux M. Salmonella meningitis in children in Blantyre, Malawi, 1996-1999. Ann Trop Peds 20 (2000) 41-44
99. Kelesidis T., Kelesidis I., Rafailidis P., and Falagas M. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimocrob Chemo 60 (2007) 214-236
100. Lambert P., and Conway B. Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin. J Chemother 15 (2003) 357-368
101. Schito G., and Keenan M. Predicting the clinical efficacy of generic formulations of ceftriaxone. J Chemother 17 suppl 2 (2005) 33-40
102. de Gans J., and van de Beek D. Dexamethasone in adults with bacterial meningitis. New Engl J Med 347 (2002) 1549-1556
103. Peltola H., Roine I., Fernandez J., et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 45 (2007) 1277-1286
104. Nguyen T., Tran T., Thwaites G., et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New Engl J Med 357 (2007) 2431-2440
105. Pitlick W., Pirikitakuhlr P., Painter M., and Wessel H. Effect of glycerol and hyperosmolality on intracranial pressure. Clin Pharmacol Ther 31 (1982) 466-471
106. Kilpi T., Peltola H., Jauhiainen T., and Kallio M. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Ped Infect Dis J 14 (1995) 270-278
107. Stephens D., Greenwood B., and Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369 (2007) 2196-2210
108. Kaplan S., and Feigin R. Treatment of meningitis in children. Ped Clins N Am 30 (1983) 259-269
109. Brouwer M., van de Beek D., Heckenberg S., Spanjaard L., and de Gans J. Hyponatraemia in adults with community-acquired bacterial meningitis. QJM 100 (2007) 37-40
110. Brown L., and Feigin R. Bacterial meningitis: fluid balance and therapy. Ped Annals 23 (1994) 93-98
111. Maconochie I., Baumer H., and Stewart M. Fluid therapy for acute bacterial meningitis. Cochrane Database of Syst Rev 1 (2008) CD004786.
112. Duke T., Mokela D., Frank D., et al. Management of meningitis in children with oral fluid restriction or intravenous fluid at maintenance volumes: a randomised trial. Ann Trop Peds 22 (2002) 145-157
113. Prasad K., and Karlupia N. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews. Resp Med 101 (2007) 2037-2043
114. Singhal S., Purnapatre K., Kalia V., et al. Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis 13 (2007) 1614-1616
115. Emergence of fluoroquinolone-resistant Neisseria meningitidis-Minnesota and North Dakota 2007-2008. MMWR 57 (2008) 173-175
116. Dery M., and Hasbun R. Changing epidemiology of bacterial meningitis. Curr Infect Dis Reps 9 (2007) 301-307
117. Cowgill K., Ndiritu M., Nyiro J., et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 296 (2006) 671-678
118. Lewis R., Kisakye A., Gessner B., et al. Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. Bull World Health Organ 86 (2008) 292-301
119. Yaro S., Lourd M., Traore Y., et al. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis 43 (2006) 693-700
120. Klugman K., Madhi S., Huebner R., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New Engl J Med 349 (2003) 1341-1348
121. Cutts F., Zaman S., Enwere G., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 (2005) 1139-1146
122. Moberley S., Holden J., Tatham D., and Andrews R. Vaccines for preventing pneumococcal infection in adults. Cochrane Database of Syst Rev 1 (2008) CD000422.
123. Robbins J., Schneerson R., Gotschlich E., et al. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Bull World Health Organ 81 (2003) 745-750
124. CDC. Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries-worldwide, 2004-2007. MMWR 57 (2008) 148-151